Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Rare Coding Variation Identifies New Genetic Contributors to Schizophrenia. | bioRxiv | 2026 | 42818077 | PubTator, text mining | PubMed |
| Autism-associated SCN2A deficiency disrupts cortico-striatal circuitry in human brain assembloids. | Neuron | 2026 | 42815470 | PubTator, text mining | PubMed |
| Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11. | Epilepsy Behav Rep | 2026 | 42774767 | PubTator, text mining | PubMed |
| Response to Electroconvulsive Therapy in a Patient With SCN2A-Variant Catatonia Is Associated With Postictal Spreading Depolarization. | J ECT | 2026 | 42768401 | PubTator, text mining | PubMed |
| Discovery of 1,4-diaryl-1,3-dihydro-2H-imidazole-2-thione anticonvulsants integrating AMPA receptor antagonism, Nav1.2 channel blockade, redox modulation, and favorable pharmacokinetic properties. | Eur J Med Chem | 2026 | 42762592 | PubTator, text mining | PubMed |
| Neuroradiologic Findings in Patients With SCN2A Disease: A Systematic Review and Retrospective Multicenter Cohort Study. | Neurology | 2026 | 42758957 | PubTator, text mining | PubMed |
| Precision therapeutics for early onset epilepsy: Allele-selective antisense oligonucleotides for SCN2A-related epilepsy. | Mol Ther Nucleic Acids | 2026 | 42751217 | PubTator, text mining | PubMed |
| CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder. | Metab Brain Dis | 2026 | 42747551 | PubTator, text mining | PubMed |
| Lvguidingan inhibits Nav1.2 and epilepsy-associated SCN2A gain-of-function variants. | Acta Pharmacol Sin | 2026 | 42745013 | PubTator, text mining | PubMed |
| [Effectiveness and tolerability of ketogenic diet therapy in children with genetic developmental and epileptic encephalopathy onset within 2 years of age]. | Zhonghua Er Ke Za Zhi | 2026 | 42742013 | PubTator, text mining | PubMed |
| Divalent cation depletion enhances intrinsic neuronal excitability through CaSR-dependent modulation of threshold ion channels. | PNAS Nexus | 2026 | 42725042 | PubTator, text mining | PubMed |
| Novel and Emerging Therapies for Childhood-Onset Movement Disorders. | Mov Disord | 2026 | 42723627 | PubTator, text mining | PubMed |
| Capillary Collection Kit Can Facilitate Newborn Screening for Hemoglobinopathies: Utilisation of Existing Infrastructure in Resource Constrained Setting. | Indian J Hematol Blood Transfus | 2026 | 42712627 | PubTator, text mining | PubMed |
| [Electroclinical recognition of SCN2A, SCN8A, KCNQ2, and KCNQ3 pathogenic variants]. | Medicina (B Aires) | 2026 | 42659555 | PubTator, text mining | PubMed |
| Antiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. | Curr Issues Mol Biol | 2026 | 42651828 | PubTator, text mining | PubMed |
| Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic-Ischaemic Encephalopathy: A Systematic Review. | Genes (Basel) | 2026 | 42650055 | PubTator, text mining | PubMed |
| Reply: "Letter to the Editor on 'Expanding the Phenotypic Spectrum of SCN2A: Generalized Dystonia without Epilepsy or Encephalopathy'". | Mov Disord Clin Pract | 2026 | 42631556 | PubTator, text mining | PubMed |
| Letter to the Editor on "Expanding the Phenotypic Spectrum of SCN2A: Generalized Dystonia without Epilepsy or Encephalopathy". | Mov Disord Clin Pract | 2026 | 42631545 | PubTator, text mining | PubMed |
| Efficacy of synthetic ACTH in confirmed and presumed monogenic developmental and epileptic encephalopathies. | Epileptic Disord | 2026 | 42615235 | PubTator, text mining | PubMed |
| Early infantile developmental and epileptic encephalopathy: clinical spectrum, diagnosis, outcomes, and evolving treatment strategies. | Brain Dev | 2026 | 42607558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers